Does ENZALUTAMIDE Cause Dyspnoea? 1,294 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,294 reports of Dyspnoea have been filed in association with ENZALUTAMIDE (Xtandi). This represents 2.6% of all adverse event reports for ENZALUTAMIDE.
1,294
Reports of Dyspnoea with ENZALUTAMIDE
2.6%
of all ENZALUTAMIDE reports
159
Deaths
411
Hospitalizations
How Dangerous Is Dyspnoea From ENZALUTAMIDE?
Of the 1,294 reports, 159 (12.3%) resulted in death, 411 (31.8%) required hospitalization, and 23 (1.8%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 1,294 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which ENZALUTAMIDE Alternatives Have Lower Dyspnoea Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE